Abstract 5599: ATG-125, a novel B7H3 × PD-L1 bispecific antibody-drug conjugate, demonstrates potent antitumor efficacy by dual targeting of immune evasion and direct tumor killing
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Jishun Chen, Suya Bai, Yu Bai, Huiling Liu, Zaoshun Hu, Jay Mei, Peng Chen, Bing Hou
Institution: Antengene Corporation Limited (China)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148676203
Cites:
Cited by:
Related to: